Antimony-induced astrocyte activation via mitogen-activated protein kinase activation-dependent CREB phosphorylation

Toxicol Lett. 2021 Nov 1:352:9-16. doi: 10.1016/j.toxlet.2021.09.006. Epub 2021 Sep 24.

Abstract

Recent studies suggest that the chemical element antimony (Sb) is neurotoxic; however, the molecular mechanisms behind Sb-related neuronal damage are currently unknown. In this study, we found that Sb exposure promoted astrocyte proliferation and increased the expression of inducible nitric oxide synthase (iNOS) and glial fibrillary acidic protein (GFAP), two key protein markers of reactive astrogliosis, at both the gene and protein level, suggesting that Sb induced astrocyte activation. Moreover, the p38 mitogen-activated protein kinase (p38 MAPK) and extracellular signal-related kinase (ERK) pathways were activated following Sb exposure. Inhibition of p38 MAPK reduced Sb-induced iNOS and GFAP upregulation, while inhibiting ERK reduced GFAP expression only, in Sb-exposed C6 cells. Sb treatment also induced the phosphorylation of cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB), and the inhibition of CREB caused a reduction in Sb-induced GFAP and iNOS expression. Furthermore, inhibiting both p38 MAPK and ERK effectively alleviated CREB phosphorylation in Sb-exposed C6 cells. Taken together, our results suggest that p38 MAPK and ERK activation mediate Sb-induced astrocyte activation through CREB phosphorylation. These results help to clarify the molecular mechanisms underlying Sb-associated neurotoxicity.

Keywords: Antimony; Astrocyte activation; CREB; ERK; p38 MAPK.

MeSH terms

  • Animals
  • Antimony / toxicity*
  • Astrocytes / drug effects*
  • Brain / cytology
  • Brain / drug effects
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • Enzyme Activation / drug effects*
  • Humans
  • Male
  • Mice
  • Mice, Inbred ICR
  • Mitogen-Activated Protein Kinase Kinases / metabolism*
  • Neuroglia / drug effects
  • Neuroglia / physiology
  • Phosphorylation / drug effects

Substances

  • CREB1 protein, human
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Antimony
  • Mitogen-Activated Protein Kinase Kinases